semaglutide and general anesthesia anesthesia - When to stop oralsemaglutidebefore surgery common Navigating the Anesthesia Landscape: Understanding Semaglutide and General Anesthesia

GLP-1anesthesiaguidelines 2025 As the popularity of medications like semaglutide, known by brand names such as Ozempic and Wegovy, continues to surge for managing diabetes and promoting weight loss, a critical conversation is emerging within the medical community: the implications of semaglutide and general anesthesia. Patients and healthcare providers alike need a clear understanding of the potential risks and necessary precautions when individuals on this medication require surgical procedures involving general anesthesia.

The Core Concern: Delayed Gastric Emptying

The primary concern surrounding semaglutide use in the perioperative period stems from its known side effect of delaying gastric emptying. This physiological effect means that food and fluids may remain in the stomach for longer than usual(PDF) Emerging Anesthesia Risks with Semaglutide. Under normal circumstances, fasting before anesthesia is a standard safety protocol to prevent regurgitation and pulmonary aspiration – the inhalation of stomach contents into the lungs, which can lead to serious respiratory complications like pneumonia.Patients Taking Popular Medications for Diabetes and ...

However, in patients taking semaglutide, even with adherence to traditional fasting guidelines, there's an increased likelihood of having residual gastric contents. Studies have indicated that patients on semaglutide might have significantly higher residual gastric content compared to those not on the medication, even after prolonged fasting periods作者：MA Gulak·2023·被引用次数：158—Patients taking long-acting GLP-1 RAs such assemaglutide may be at risk of pulmonary aspiration under anesthesia. We propose strategies to .... This phenomenon has led to case reports detailing instances of patients on semaglutide experiencing regurgitation and pulmonary aspiration under anesthesia, despite having followed pre-operative fasting instructions.

Expert Recommendations and Emerging Guidelines

The medical consensus is evolving, with professional organizations and researchers actively investigating and disseminating guidance.2023年8月13日—Champeau and Jones both acknowledged there's not enough evidence to say for certain how longsemaglutideshould be held to makeanesthesiasafe. Evidence suggests that a standard 8-hour fasting period may not be sufficient for patients on semaglutide. Consequently, recommendations are shifting towards longer pre-operative withholding periods.

Multiple research groups and societies are exploring the optimal timing for discontinuing semaglutide before surgery. Some studies and reports suggest withholding the medication for at least seven days prior to planned anesthesia, a period that aligns with the drug's approximate 7-day half-life. In fact, some newer analyses are even recommending a longer discontinuation period of up to three weeks before elective surgery, particularly under general anesthesia. The American Society of Anesthesiologists (ASA) Task Force on Preoperative Fasting issued a recommendation in July 2023 to hold GLP-1 receptor agonists, including semaglutide, for a specified period before procedures.

It's important to note that while research is ongoing, there's not yet a universally agreed-upon definitive timeline applicable to all patients. Factors such as individual patient response, the specific type of anesthesia (e作者：WB Beam—We describe two cases of patients taking GLP-1 receptor agonists that were found to have high volumes of complex gastric contents despite appropriate fasting..g2025年1月28日—GLP-1 and dual GIP/GLP-1 receptor agonists:potential risk of pulmonary aspiration during general anaesthesiaor deep sedation. Healthcare ...., general anesthesia, local anesthesia), and the nature of the surgical procedure can all play a role. However, the overarching message for semaglutide and its impact on anesthesia is to err on the side of cautionGlucagon-Like Peptide-1 Agonists and General Anesthesia.

Understanding the Risks of Pulmonary Aspiration

The potential risk of pulmonary aspiration during general anaesthesia is a significant concern for individuals on semaglutide. When the muscles of the body relax under general anaesthetic, the risk of stomach contents moving into the airway increases if the stomach is not sufficiently empty. This can lead to potentially life-threatening complications, including aspiration pneumonia, acute respiratory distress syndrome (ARDS), and even death.作者：SA Avraham·2024·被引用次数：45—The recommendation for patients taking semaglutide is towithhold the medication for a week prior to anaesthesia, based on its 7-day half-life. The presence of complex gastric contents, as reported in some case studies, further exacerbates this risk.

Restarting Semaglutide After Surgery

For patients who have undergone surgery and required the discontinuation of their semaglutide medication, a discussion regarding restarting the drug is also crucial. The timing for resuming semaglutide will depend on the patient's recovery, the type of surgery performed, and the advice of their healthcare provider. It is generally recommended to consult with your prescribing physician before restarting any medication after a surgical procedure.

Comprehensive Pre-Operative Assessment is Key

When a patient on semaglutide is scheduled for a procedure requiring anesthesia, a thorough pre-operative assessment is paramount. Anesthesiologists must be aware of the potential for delayed gastric emptying and the associated risks. This awareness allows for the implementation of alternative intraoperative strategies to ensure patient safetyGLP-1 and dual GIP/GLP-1 receptor agonists: potential risk .... Open communication between the patient, their surgeon, and the anesthesia team is vitalMost patients can continue GLP-1 anti-obesity drugs before surgery. Patients should inform their healthcare providers about all medications they are taking, including semaglutide and other GLP-1 receptor agonists or dual GIP/GLP-1 receptor agonists, as well as any other medications for diabetes or weight loss.

Conclusion: A Collaborative Approach to Safe Anesthesia

The intersection of semaglutide and general anesthesia highlights the evolving nature of medical practice in response to new therapeutic agents. While semaglutide offers significant benefits for numerous patients, understanding and mitigating its potential risks during medical procedures is essential. By staying informed about the latest research, adhering to updated guidelines, and fostering open communication among healthcare teams and patients, the goal of safe and effective anesthesia can be achieved.New Study Recommends Stopping GLP-1 Agonists 14 Days ... This proactive approach ensures that the benefits of semaglutide can be enjoyed without compromising patient safety during surgical interventions.